Postictal affective episodes

Andres M Kanner, Michael Trimble, Bettina Schmitz

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Despite their recognition two centuries ago, postictal depression symptoms (PDSs) and episodes (PDEs) continue to be ignored by most clinicians in their evaluation of patients with epilepsy. And yet, PDSs are relatively frequent in patients with pharmacoresistant epilepsy, having been identified in almost 50% of patients with a median duration of 24. hours. PDSs may be the expression of symptoms restricted to the postictal period (defined as the first 5. days following a seizure) and/or may be the expression of postictal exacerbation in severity of interictal symptoms of depression. In fact, a past history of depressive and anxiety disorders has been associated with the occurrence of PDSs and PSEs. PDSs and PSEs often occur together with postictal symptoms of anxiety, and the occurrence of PDSs has been associated with more severe postictal cognitive deficits. The occurrence of PDSs and PDEs has not been associated with any epilepsy-related variable (location of seizure focus, MRI findings, type of antiepileptic drug). Prevention of PDSs and PDEs can be achieved only with seizure freedom, and preliminary uncontrolled data suggest that being on antidepressant medication does not protect patients from experiencing these types of symptoms.

Original languageEnglish (US)
Pages (from-to)156-158
Number of pages3
JournalEpilepsy and Behavior
Volume19
Issue number2
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Depression
Epilepsy
Seizures
Depressive Disorder
Anxiety Disorders
Anticonvulsants
Antidepressive Agents
Anxiety

Keywords

  • Pharmacoresistant epilepsy
  • Postictal anxiety
  • Postictal depression
  • Postictal suicidality

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Postictal affective episodes. / Kanner, Andres M; Trimble, Michael; Schmitz, Bettina.

In: Epilepsy and Behavior, Vol. 19, No. 2, 10.2010, p. 156-158.

Research output: Contribution to journalArticle

Kanner, Andres M ; Trimble, Michael ; Schmitz, Bettina. / Postictal affective episodes. In: Epilepsy and Behavior. 2010 ; Vol. 19, No. 2. pp. 156-158.
@article{f57cdff3bd3d47389bf5861cd5e3dfa2,
title = "Postictal affective episodes",
abstract = "Despite their recognition two centuries ago, postictal depression symptoms (PDSs) and episodes (PDEs) continue to be ignored by most clinicians in their evaluation of patients with epilepsy. And yet, PDSs are relatively frequent in patients with pharmacoresistant epilepsy, having been identified in almost 50{\%} of patients with a median duration of 24. hours. PDSs may be the expression of symptoms restricted to the postictal period (defined as the first 5. days following a seizure) and/or may be the expression of postictal exacerbation in severity of interictal symptoms of depression. In fact, a past history of depressive and anxiety disorders has been associated with the occurrence of PDSs and PSEs. PDSs and PSEs often occur together with postictal symptoms of anxiety, and the occurrence of PDSs has been associated with more severe postictal cognitive deficits. The occurrence of PDSs and PDEs has not been associated with any epilepsy-related variable (location of seizure focus, MRI findings, type of antiepileptic drug). Prevention of PDSs and PDEs can be achieved only with seizure freedom, and preliminary uncontrolled data suggest that being on antidepressant medication does not protect patients from experiencing these types of symptoms.",
keywords = "Pharmacoresistant epilepsy, Postictal anxiety, Postictal depression, Postictal suicidality",
author = "Kanner, {Andres M} and Michael Trimble and Bettina Schmitz",
year = "2010",
month = "10",
doi = "10.1016/j.yebeh.2010.06.024",
language = "English (US)",
volume = "19",
pages = "156--158",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Postictal affective episodes

AU - Kanner, Andres M

AU - Trimble, Michael

AU - Schmitz, Bettina

PY - 2010/10

Y1 - 2010/10

N2 - Despite their recognition two centuries ago, postictal depression symptoms (PDSs) and episodes (PDEs) continue to be ignored by most clinicians in their evaluation of patients with epilepsy. And yet, PDSs are relatively frequent in patients with pharmacoresistant epilepsy, having been identified in almost 50% of patients with a median duration of 24. hours. PDSs may be the expression of symptoms restricted to the postictal period (defined as the first 5. days following a seizure) and/or may be the expression of postictal exacerbation in severity of interictal symptoms of depression. In fact, a past history of depressive and anxiety disorders has been associated with the occurrence of PDSs and PSEs. PDSs and PSEs often occur together with postictal symptoms of anxiety, and the occurrence of PDSs has been associated with more severe postictal cognitive deficits. The occurrence of PDSs and PDEs has not been associated with any epilepsy-related variable (location of seizure focus, MRI findings, type of antiepileptic drug). Prevention of PDSs and PDEs can be achieved only with seizure freedom, and preliminary uncontrolled data suggest that being on antidepressant medication does not protect patients from experiencing these types of symptoms.

AB - Despite their recognition two centuries ago, postictal depression symptoms (PDSs) and episodes (PDEs) continue to be ignored by most clinicians in their evaluation of patients with epilepsy. And yet, PDSs are relatively frequent in patients with pharmacoresistant epilepsy, having been identified in almost 50% of patients with a median duration of 24. hours. PDSs may be the expression of symptoms restricted to the postictal period (defined as the first 5. days following a seizure) and/or may be the expression of postictal exacerbation in severity of interictal symptoms of depression. In fact, a past history of depressive and anxiety disorders has been associated with the occurrence of PDSs and PSEs. PDSs and PSEs often occur together with postictal symptoms of anxiety, and the occurrence of PDSs has been associated with more severe postictal cognitive deficits. The occurrence of PDSs and PDEs has not been associated with any epilepsy-related variable (location of seizure focus, MRI findings, type of antiepileptic drug). Prevention of PDSs and PDEs can be achieved only with seizure freedom, and preliminary uncontrolled data suggest that being on antidepressant medication does not protect patients from experiencing these types of symptoms.

KW - Pharmacoresistant epilepsy

KW - Postictal anxiety

KW - Postictal depression

KW - Postictal suicidality

UR - http://www.scopus.com/inward/record.url?scp=77957342888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957342888&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2010.06.024

DO - 10.1016/j.yebeh.2010.06.024

M3 - Article

VL - 19

SP - 156

EP - 158

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 2

ER -